These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30552333)

  • 1. Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.
    Ogorodnikov A; Levin M; Tattikota S; Tokalov S; Hoque M; Scherzinger D; Marini F; Poetsch A; Binder H; Macher-Göppinger S; Probst HC; Tian B; Schaefer M; Lackner KJ; Westermann F; Danckwardt S
    Nat Commun; 2018 Dec; 9(1):5331. PubMed ID: 30552333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Intronic Polyadenylation by PCF11 Impacts mRNA Expression of Long Genes.
    Wang R; Zheng D; Wei L; Ding Q; Tian B
    Cell Rep; 2019 Mar; 26(10):2766-2778.e6. PubMed ID: 30840896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA 3'end processing: A tale of the tail reaches the clinic.
    Hollerer I; Grund K; Hentze MW; Kulozik AE
    EMBO Mol Med; 2014 Jan; 6(1):16-26. PubMed ID: 24408965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.
    Creemers EE; Bawazeer A; Ugalde AP; van Deutekom HW; van der Made I; de Groot NE; Adriaens ME; Cook SA; Bezzina CR; Hubner N; van der Velden J; Elkon R; Agami R; Pinto YM
    Circ Res; 2016 Feb; 118(3):433-8. PubMed ID: 26671978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal virulence and development is regulated by alternative pre-mRNA 3'end processing in Magnaporthe oryzae.
    Franceschetti M; Bueno E; Wilson RA; Tucker SL; Gómez-Mena C; Calder G; Sesma A
    PLoS Pathog; 2011 Dec; 7(12):e1002441. PubMed ID: 22194688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
    Hardy JG; Norbury CJ
    Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and function of alternative polyadenylation in development and differentiation.
    Gallicchio L; Olivares GH; Berry CW; Fuller MT
    RNA Biol; 2023 Jan; 20(1):908-925. PubMed ID: 37906624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome Analyses of FY Mutants Reveal Its Role in mRNA Alternative Polyadenylation.
    Yu Z; Lin J; Li QQ
    Plant Cell; 2019 Oct; 31(10):2332-2352. PubMed ID: 31427469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Roles of Vertebrate PCF11 in Premature and Full-Length Transcript Termination.
    Kamieniarz-Gdula K; Gdula MR; Panser K; Nojima T; Monks J; Wiśniewski JR; Riepsaame J; Brockdorff N; Pauli A; Proudfoot NJ
    Mol Cell; 2019 Apr; 74(1):158-172.e9. PubMed ID: 30819644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage factor Im is a key regulator of 3' UTR length.
    Gruber AR; Martin G; Keller W; Zavolan M
    RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative polyadenylation analysis in animals and plants: newly developed strategies for profiling, processing and validation.
    Zhang Y; Carrion SA; Zhang Y; Zhang X; Zinski AL; Michal JJ; Jiang Z
    Int J Biol Sci; 2018; 14(12):1709-1714. PubMed ID: 30416385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shift in MSL1 alternative polyadenylation in response to DNA damage protects cancer cells from chemotherapeutic agent-induced apoptosis.
    Kunisky AK; Anyaeche VI; Herron RS; Park CY; Hwang HW
    Cell Rep; 2021 Oct; 37(2):109815. PubMed ID: 34644577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREND-DB-a transcriptome-wide atlas of the dynamic landscape of alternative polyadenylation.
    Marini F; Scherzinger D; Danckwardt S
    Nucleic Acids Res; 2021 Jan; 49(D1):D243-D253. PubMed ID: 32976578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPRpas: programmable regulation of alternative polyadenylation by dCas9.
    Shin J; Ding Q; Wang L; Cui Y; Baljinnyam E; Guvenek A; Tian B
    Nucleic Acids Res; 2022 Mar; 50(5):e25. PubMed ID: 34244761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative polyadenylation: methods, mechanism, function, and role in cancer.
    Zhang Y; Liu L; Qiu Q; Zhou Q; Ding J; Lu Y; Liu P
    J Exp Clin Cancer Res; 2021 Feb; 40(1):51. PubMed ID: 33526057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.
    Matoulkova E; Michalova E; Vojtesek B; Hrstka R
    RNA Biol; 2012 May; 9(5):563-76. PubMed ID: 22614827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early noncoding region of human papillomavirus type 16 is regulated by cytoplasmic polyadenylation factors.
    Glahder JA; Kristiansen K; Durand M; Vinther J; Norrild B
    Virus Res; 2010 May; 149(2):217-23. PubMed ID: 20144904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread transcript shortening through alternative polyadenylation in secretory cell differentiation.
    Cheng LC; Zheng D; Baljinnyam E; Sun F; Ogami K; Yeung PL; Hoque M; Lu CW; Manley JL; Tian B
    Nat Commun; 2020 Jun; 11(1):3182. PubMed ID: 32576858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.